![Paul Grayson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Grayson
Chairman at
SKYE BIOSCIENCE, INC.
Net worth: 20 609 $ as of 2026-08-30
Profile
Mr. Paul A. Grayson is a Chairman at Skye Bioscience, Inc., a President, Chief Executive Officer & Director at Radionetics Oncology, Inc., a Member at Aurora Biosciences Corp.
and a President & Chief Executive Officer at RuiYi, Inc. (China).
He is on the Board of Directors at Radionetics Oncology, Inc. Mr. Grayson was previously employed as a President & Chief Executive Officer by Tentarix Biotherapeutics LP, a President, Chief Executive Officer & Director by Tentarix Biotherapeutics, Inc., a Venture Partner by Versant Venture Management LLC, a President, Chief Executive Officer & Director by Bird Rock Bio Sub, Inc., a President & Chief Executive Officer by Fate Therapeutics, Inc., a Managing Director by Sanderling Management CO LLC, a President & Chief Executive Officer by Senomyx, Inc., a Chairman by CalciMedica Subsidiary, Inc., and a Chairman by Naviscan, Inc. He also served on the board at Progenitor Labs Ltd., Apoptos, Inc., Chimerix, Inc., Pipeline Therapeutics, Inc., Receptos LLC, Ren Pharmaceuticals, Inc. and TempestTx, Inc. He received his undergraduate degree from the University of California, Los Angeles and an MBA from the University of California, Irvine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 12,267 ( 0.28% ) | 20 609 $ | 2026-08-30 |
Paul Grayson active positions
| Companies | Position | Start |
|---|---|---|
| SKYE BIOSCIENCE, INC. | Chairman | 2024-10-24 |
Aurora Biosciences Corp.
 Aurora Biosciences Corp. BiotechnologyHealth Technology Designs and develops proprietary drug discovery systems, services and technologies | Corporate Officer/Principal | 2010-04-20 |
Radionetics Oncology, Inc.
 Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that discovers and develops novel radio therapeutics for the treatment of oncology indications | Chief Executive Officer | 2023-06-30 |
RuiYi, Inc. (China)
 RuiYi, Inc. (China) BiotechnologyHealth Technology Develops biologic therapies | Chief Executive Officer | - |
Former positions of Paul Grayson
| Companies | Position | End |
|---|---|---|
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Private Equity Investor | 2023-12-31 |
Tentarix Biotherapeutics LP
 Tentarix Biotherapeutics LP BiotechnologyHealth Technology Operates as a biotechnology company | Chief Executive Officer | 2023-12-31 |
Tentarix Biotherapeutics, Inc.
 Tentarix Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company for intelligent therapies with multifunctional biologics | Chief Executive Officer | 2023-10-31 |
| CONTINEUM THERAPEUTICS, INC. | Director/Board Member | 2023-10-31 |
Bird Rock Bio Sub, Inc.
 Bird Rock Bio Sub, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Chief Executive Officer | 2023-08-17 |
Training of Paul Grayson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
85
1st degree connections
22
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 22 |
|---|---|
Aurora Biosciences Corp.
Aurora Biosciences Corp. BiotechnologyHealth Technology Designs and develops proprietary drug discovery systems, services and technologies | Health Technology |
Senomyx, Inc.
 Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Discovers and develops novel flavors and taste modulators for the packaged food and beverage industry | Consumer Non-Durables |
Sanderling Management CO LLC
 Sanderling Management CO LLC Investment ManagersFinance Sanderling Ventures invests in companies located in the United States. The firm participates in seed and early-stage capital transactions. It focuses on sectors such as biomedical and emerging technology. | Finance |
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Naviscan, Inc.
 Naviscan, Inc. Electronic Production EquipmentElectronic Technology Develops, manufactures, and markets organ molecular imaging scanners | Electronic Technology |
Ren Pharmaceuticals, Inc.
 Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceuticals products | Health Technology |
CalciMedica Subsidiary, Inc.
 CalciMedica Subsidiary, Inc. BiotechnologyHealth Technology Engages in drug development | Health Technology |
Apoptos, Inc.
 Apoptos, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule anticancer drugs | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
TempestTx, Inc.
 TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Bird Rock Bio Sub, Inc.
Bird Rock Bio Sub, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
RuiYi, Inc. (China)
RuiYi, Inc. (China) BiotechnologyHealth Technology Develops biologic therapies | Health Technology |
Progenitor Labs Ltd.
 Progenitor Labs Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs to regenerate specific tissues of the human body in response to injury, disease, and ageing | Health Technology |
Skye Bioscience, Inc.
 Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Pipeline Therapeutics, Inc.
 Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
Tentarix Biotherapeutics LP
Tentarix Biotherapeutics LP BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Tentarix Biotherapeutics, Inc.
Tentarix Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company for intelligent therapies with multifunctional biologics | Health Technology |
Radionetics Oncology, Inc.
Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that discovers and develops novel radio therapeutics for the treatment of oncology indications | Health Technology |
- Stock Market
- Insiders
- Paul Grayson
